433 related articles for article (PubMed ID: 10980925)
1. Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid.
Lee YM; Kaplan MM
Curr Gastroenterol Rep; 1999; 1(1):38-41. PubMed ID: 10980925
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Hay JE
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis].
Stiehl A
Z Gastroenterol; 2002 Dec; 40 Suppl 2():29-30. PubMed ID: 12467002
[No Abstract] [Full Text] [Related]
5. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Rust C; Beuers U
Clin Rev Allergy Immunol; 2005 Apr; 28(2):135-45. PubMed ID: 15879619
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Holtmeier J; Leuschner U
Digestion; 2001; 64(3):137-50. PubMed ID: 11786661
[TBL] [Abstract][Full Text] [Related]
7. Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis.
Zein CO; Lindor KD
Curr Gastroenterol Rep; 2010 Feb; 12(1):13-22. PubMed ID: 20425480
[TBL] [Abstract][Full Text] [Related]
8. [Ursodeoxycholic acid--a new therapy concept in cholestatic liver diseases].
Raedsch R; Stiehl A
Klin Wochenschr; 1989 Feb; 67(4):265-8. PubMed ID: 2648062
[No Abstract] [Full Text] [Related]
9. Ursodeoxycholic acid: a second look. Primary biliary cirrhosis: dashed hopes.
Prescrire Int; 2002 Jun; 11(59):67-9. PubMed ID: 12068838
[TBL] [Abstract][Full Text] [Related]
10. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
Smith T; Befeler AS
Curr Gastroenterol Rep; 2007 Mar; 9(1):54-9. PubMed ID: 17335678
[TBL] [Abstract][Full Text] [Related]
11. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
Ahn DW
Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
[TBL] [Abstract][Full Text] [Related]
12. Bile acids for primary sclerosing cholangitis.
Poropat G; Giljaca V; Stimac D; Gluud C
Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD003626. PubMed ID: 21249655
[TBL] [Abstract][Full Text] [Related]
13. The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis.
Floreani A; Motta R; Cazzagon N; Franceschet I; Roncalli M; Del Ross T; Rosina F; Lleo A; Mescoli C; Colloredo G; Invernizzi P
Dig Liver Dis; 2015 May; 47(5):432-5. PubMed ID: 25747115
[TBL] [Abstract][Full Text] [Related]
14. Management of cholestatic disease in 2017.
de Vries E; Beuers U
Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy of cholestatic hepatopathies].
Leuschner U
Schweiz Rundsch Med Prax; 1992 Aug; 81(34):983-4. PubMed ID: 1529191
[TBL] [Abstract][Full Text] [Related]
16. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease.
Beuers U; Spengler U; Zwiebel FM; Pauletzki J; Fischer S; Paumgartner G
Hepatology; 1992 Apr; 15(4):603-8. PubMed ID: 1551637
[TBL] [Abstract][Full Text] [Related]
17. Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?
Gisbert JP; Jones EA; Pajares JM; Moreno-Otero R
Aliment Pharmacol Ther; 2003 Jan; 17(1):17-27. PubMed ID: 12492729
[TBL] [Abstract][Full Text] [Related]
18. [Physico-chemical properties of ursodeoxycholic acid and its usefulness in hepatopathies].
Méndez Sánchez N; Coté C; Aguilar Ramírez A; Uribe M
Rev Gastroenterol Mex; 1992; 57(3):183-90. PubMed ID: 1308299
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of cholestatic liver diseases].
Karvonen AL
Duodecim; 2003; 119(6):533-9. PubMed ID: 12708340
[No Abstract] [Full Text] [Related]
20. Ursodeoxycholic acid for the treatment of cholestatic diseases.
Poupon RE; Poupon R
Prog Liver Dis; 1992; 10():219-38. PubMed ID: 1296231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
